# Preparing an Omics Innovation Project Proposal

Designing a persuasive omics proposal means demonstrating that your idea is significant, innovative, and executable with the resources and time available. Use the assignment brief (`assesments/Omics_Project_Proposal.md`) as the baseline deliverable and follow the guidance below to turn it into a professional, grant-style document.

## 1. Start With Strategy
- **Clarify the unmet need.** Review the provided articles, recent reviews, and datasets to pinpoint what knowledge gap or application remains unsolved.
- **Define stakeholders.** Note whether the proposal targets an academic call, a personal fellowship, or an industry sponsor—tone and success metrics differ.
- **Collect constraints.** Deadlines, page limits (10–20 pages), figure requirements (≥3), citation style, and oral presentation expectations shape content density and layout.
- **Build a reference library early.** Use Zotero or Mendeley to store citations, annotate PDFs, and generate bibliographies.

## 2. Recommended Outline and Writing Advice
The table extends the assignment structure with key questions, signals of quality, and pitfalls to avoid.

| Section | What to Answer | Good Practices | Pitfalls |
| --- | --- | --- | --- |
| **Title & Abstract** | What problem are you solving and what is the innovation? | Front-load the unmet need, keep abstract 200–250 words, include 3–5 keywords. | Overly technical jargon, hiding the hypothesis. |
| **Background & State of the Art** | Why does the problem matter now? | Tell a story from broad context to the gap; use well-curated figures/tables; cite no more than necessary. | Literature dump without synthesis or link to proposal. |
| **Hypothesis & Rationale** | What is your central testable claim and why is it credible? | Phrase as a falsifiable statement; connect to cited evidence; highlight novelty. | Vague statements (“We explore if multi-omics is useful”). |
| **Objectives & Work Plan** | How will you break the hypothesis into actionable work? | 2–4 SMART objectives; align each with a work package, deliverable, timeline, and dependency; include a Gantt chart. | Too many objectives, no link to methods or milestones. |
| **Methodology & Approach** | What experimental/computational steps ensure feasibility? | Provide detailed sample strategy, platforms, QC, bioinformatics workflows, and validation plans; specify computing/storage resources. | Glossing over QC, data management, or ethics. |
| **Expected Results & Data Analysis** | What outputs will convince reviewers the project works? | Explain analysis pipelines, statistical tests, ML models, metrics for success, and visualization plans. | Predicting specific results without discussing alternative interpretations. |
| **Innovation & Translational Impact** | How does this change the field or market? | Compare to state of the art, emphasize interdisciplinarity, describe paths to clinical/industrial adoption. | Buzzwords without concrete differentiation. |
| **Risk & Contingencies** | What could fail and what is Plan B? | Use a risk matrix (likelihood × impact), list technical/data/ethical risks, pair each with mitigation. | Ignoring data access or regulatory risks. |
| **Team, Resources & Environment** | Who will deliver and where? | Map expertise to tasks, highlight collaborators, detail lab/HPC resources, data governance. | Overlapping roles or missing critical skills. |
| **Ethical, Legal & Societal Implications (ELSI)** | How will you handle data privacy, consent, equity? | Reference GDPR, Declaration of Helsinki, institutional review steps, data-sharing plans. | Treating ELSI as an afterthought. |
| **Impact & Future Perspective** | What is the post-project trajectory? | Show scalability, follow-on funding targets, commercialization or open-science roadmap. | Overclaiming impact with no evidence or timeline. |
| **References, Figures & Tables** | How will you support and illustrate the narrative? | Use consistent citation style, ensure all figures are self-explanatory, include legends and data sources. | Missing citations, low-resolution or borrowed figures without permission. |

## 3. Writing Each Section in Detail
### 3.1 Title & Abstract
1. Draft multiple versions of the title combining target (disease/technology) + method + outcome. Example: “Integrating Single-Cell Spatial Transcriptomics and Proteomics to Map Fibrotic Niches in NASH.”
2. Abstract checklist:
   - Sentence 1–2: unmet need + significance.
   - Sentence 3–4: hypothesis and objectives.
   - Sentence 5–6: methodological approach (platforms, data types).
   - Sentence 7: expected translational impact.
   - Optional: keywords.
3. Revise last; ensure consistency with final work plan and methods.

### 3.2 Background & State of the Art
- Construct a concept map linking disease area, omics layers, and technologies.
- Summarize pivotal papers in a table (columns: Reference, Dataset, Key Finding, Relevance to Proposal).
- Highlight conflicting evidence and unresolved debates—these justify your project.
- Close with a crisp gap statement (“However, no studies have integrated…”).

### 3.3 Hypothesis & Rationale
- Frame as: “We hypothesize that [mechanism], therefore [testable outcome].”
- Provide 2–3 supporting arguments (preliminary data, published evidence, technological readiness).
- If targeting industry or clinical translation, include expected benefit to users/patients.

### 3.4 Objectives & Work Packages
- Draft a one-paragraph overview linking objectives to hypothesis.
- For each WP create a mini-structure:
  1. **Aim** (1 sentence).
  2. **Approach** (methods, datasets, tools).
  3. **Deliverables** (dataset, algorithm, assay).
  4. **Milestones** with timelines (e.g., M3: IRB approval; M9: multi-omic integration pipeline ready).
- Include dependencies and decision points (e.g., “WP2 begins after QC metrics from WP1 exceed X”).

### 3.5 Methodology & Approach
- Organize by objective or data layer (genomics, transcriptomics, proteomics, metabolomics).
- Detail:
  - **Study design** (case-control, longitudinal, organ-on-chip experiments). Justify statistical power assumptions with sample-size formulas.
  - **Sample handling** (collection, storage, SOPs, randomization, batch control).
  - **Sequencing/omics platforms** with version numbers, coverage, read lengths, QC thresholds.
  - **Bioinformatics** (pipeline diagrams, software versions, containerization, reproducibility strategy such as Nextflow + nf-core).
  - **Validation** (orthogonal assays, independent cohorts, benchmarking datasets).
  - **Data management** (FAIR principles, metadata standards, repositories like GEO/ENA/Zenodo).
  - **Ethics & regulatory** specifics (consent wording, data access committees, licensing of proprietary tools).
- Insert a flowchart summarizing sample-to-insight steps.

### 3.6 Expected Results & Data Analysis
- Describe output types (variant catalogs, expression matrices, predictive models) and success metrics (AUC, differential expression FDR, effect sizes).
- Explain statistical or ML approaches (e.g., mixed models, Bayesian network inference, graph neural networks) and how you will avoid overfitting (cross-validation, independent validation set).
- Plan figures: volcano plots, spatial maps, integrative Sankey diagrams, etc.

### 3.7 Innovation & Translational Impact
- Use comparative statements: “Unlike prior NASH atlases that analyze scRNA-seq alone (Smith et al., 2023), we integrate spatial proteomics to map paracrine gradients.”
- Outline user pathway: discovery → prototype → validation → regulatory/partner engagement.
- Mention IP strategy, potential spin-offs, or clinical trial readiness where relevant.

### 3.8 Risk & Contingency Plans 
- Not totaly needed but important part in a real grant proposal. 
- Build a table listing risk, likelihood, impact, mitigation, contingency trigger.
- Example mitigations: alternate cohorts, targeted sequencing fallback, partnerships for sample sourcing, virtualization for HPC shortages.

### 3.9 Team, Resources & Environment
- Align to available (or imaginary Team) and their strengths. 
- Highlight available infrastructure: sequencing core, mass spec, HPC cluster, secure data rooms, cloud credits.
- Add letters of support or collaboration statements if available (even summaries in proposal).

### 3.10 Ethical, Legal & Societal Implications (ELSI)
- Discuss consent models (broad vs. tiered), re-identification risks, data-sharing licenses (CC BY vs. restricted), and equity/inclusion strategies.
- Reference established frameworks: Declaration of Helsinki, Belmont Report, GDPR, NIH Genomic Data Sharing Policy.
- Add a data governance workflow (access control, audit trails, compliance officer).

### 3.11 Expected Impact & Future Perspectives
- Provide a realistic 2–5 year roadmap: Phase I (current proposal), Phase II (scale-up), Phase III (clinical/industrial deployment).
- Identify future funding calls (e.g., ERC Consolidator, NIH R01, Innovate UK) and how preliminary data strengthens competitiveness.
- Highlight broader benefits (patient stratification, cost savings, new biomarkers, sustainability of workflows).

### 3.12 References, Figures & Tables
- Choose a citation manager style before drafting; avoid last-minute changes.
- Ensure every figure/table has a caption, data source, and is referenced in text.
- Prefer self-generated diagrams (BioRender, PowerPoint, draw.io) to avoid licensing issues.

## 4. Writing Workflow
1. **Scoping (day 1-2):** Select articles, define gap, assemble bibliography.
2. **Outline (Week 1):** Draft bullet outline per section, design tentative figures.
3. **Drafting (Week 1):** Write Background, Methods, Work Plan first; Abstract and Impact last.
4. **Review (Week 2):** Peer review for clarity and feasibility; run a compliance checklist (length, figures, references, ethics statements).
5. **Polish (Week 2):** Edit for flow, add visual consistency, ensure Gantt chart and risk matrix are finalized. Export to PDF and prepare presentation slides that mirror the written structure.

## 5. Advice Tailored to Proposal Types
- **Research grants (public agencies):** Focus on scientific merit, innovation, and broader impacts (open science, training students, societal benefits).
- **Industry collaborations:** Include an executive summary, highlight ROI, timelines, deliverables, IP terms, and data security; keep language concise and application-focused.

## 6. Useful Tools & Resources
- **Proposal writing guidance:**
  - PubMedCentral, article - How to prepare a Research Proposal Asya Al-Riyami, Oman Med J. 2008 Apr;23(2):66–69. https://pmc.ncbi.nlm.nih.gov/articles/PMC3282423/ 
  - NIH “How to Write a Research Project Grant Application”: https://grants.nih.gov/grants/how-to-apply-application-guide/
  - Nature Masterclasses on grant writing (Persuasive Grant Writing): https://masterclasses.nature.com/
  - Penn State Project Proposal Guide: https://oge.mit.edu/fellowships/fellowship-tips/drafting-a-research-proposal/ 
  - MIT “How to Write a Successful Research Proposal”: https://oge.mit.edu/professional-development/communication/writing-successful-proposal/     https://oge.mit.edu/fellowships/wp-content/uploads/sites/5/2022/06/HHMI-Fellowship-Writing-1-13.pdf
- **Industry-focused tips:** Iowa State University tech transfer guidance: https://www.techtransfer.iastate.edu/wp-content/uploads/2018/01/4.-Writing-Successful-Industry-Proposals.pdf 
- **General research proposal examples:** To much for this assesment but great template to admire
  - ERC proposal templates: https://erc.europa.eu/manage-your-project/preparing-your-proposal
  - Horizon Europe guidance: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/how-to-prepare-a-proposal_en.pdf
- **Omics data and workflow resources:**
  - GEO: https://www.ncbi.nlm.nih.gov/geo/
  - ENCODE: https://www.encodeproject.org/
  - GA4GH standards: https://www.ga4gh.org/
- **Project management & visualization:**
  - ProjectLibre (Gantt): https://www.projectlibre.com/
  - BioRender diagrams: https://biorender.com/
- **Ethics & data governance:**
  - GDPR overview: https://gdpr-info.eu/
  - NIH Genomic Data Sharing Policy: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-14-124.html

## 7. Final Checklist Before Submission
- [ ] Title and abstract reflect final content.
- [ ] Objectives, methods, and impact are aligned and cross-referenced.
- [ ] Figures/tables meet quantity and quality requirements, include legends, and are cited in text.
- [ ] Risk, ethics, and data management statements are complete.
- [ ] References use a consistent style and all in-text citations are in the bibliography.
- [ ] PDF export maintains formatting; Word/PDF file names follow submission guidelines.
- [ ] Oral presentation deck mirrors written structure with at least one original workflow figure.

By combining a sharp narrative with rigorous methodology, risk planning, and a clear translation pathway, you will deliver an omics proposal that convinces reviewers across academic, clinical, and industry settings.
